Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Short-term Investments history
Currency unavailable · from the balance sheet
No Short-term Investments data reported for this period type.
Short-term Investments vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $615.55M USD | +7.5% | +131.4% | 29.3% | |
| Mar 2026 | $81.03M USD | -39.6% | -1.5% | 10.9% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 49.2M SEK | — | — | 51.3% |
| Mar 2026 | $12.31M USD | -17.1% | — | 7.6% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -17.1% | +64.9% | 20.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.